This site is intended for healthcare professionals
News

Phase III studies of V 114 meet objectives in pneumococcal disease.- Merck Inc

Read time: 1 mins
Last updated:23th Jun 2020
Published:23th Jun 2020
Condition: Pneumococcal Disease
Type: drug
Register free for full access to medthority.com